Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.31 USD | -0.87% | -2.92% | -45.54% |
09/02 | Embecta Keeps Quarterly Dividend at $0.15 a Share, Payable March 15 to Shareholders as of Feb. 28 | MT |
09/02 | Sector Update: Health Care Stocks Mixed Pre-Bell Friday | MT |
Sales 2024 * | 1.11B 92.58B | Sales 2025 * | 1.11B 92.92B | Capitalization | 594M 49.5B |
---|---|---|---|---|---|
Net income 2024 * | 51M 4.25B | Net income 2025 * | 99M 8.25B | EV / Sales 2024 * | 1.55 x |
Net Debt 2024 * | 1.13B 94.38B | Net Debt 2025 * | 1.01B 84.39B | EV / Sales 2025 * | 1.44 x |
P/E ratio 2024 * |
11.7
x | P/E ratio 2025 * |
6.12
x | Employees | 2,200 |
Yield 2024 * |
5.42% | Yield 2025 * |
5.39% | Free-Float | 99.53% |
Latest transcript on Embecta Corp.
1 day | -0.87% | ||
1 week | -2.92% | ||
Current month | -22.31% | ||
1 month | -16.52% | ||
3 months | -40.40% | ||
6 months | -30.67% | ||
Current year | -45.54% |
Managers | Title | Age | Since |
---|---|---|---|
Devdatt Kurdikar
CEO | Chief Executive Officer | 56 | 22/22/22 |
Jacob Elguicze
DFI | Director of Finance/CFO | 51 | 22/22/22 |
Colleen Riley
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 01/22/01 | |
Karen Prange
BRD | Director/Board Member | 60 | 01/22/01 |
Robert Hombach
BRD | Director/Board Member | 58 | 20/22/20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.34% | 27 M€ | -5.03% | - | |
0.08% | 45 M€ | +0.20% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 10.31 | -0.87% | 264,117 |
25/24/25 | 10.4 | -4.50% | 488,927 |
24/24/24 | 10.89 | +0.09% | 284,241 |
23/24/23 | 10.88 | +1.49% | 357,508 |
22/24/22 | 10.72 | +0.94% | 408,666 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.54% | 594M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- EMBC Stock